Effects of famotidine and cimetidine on plasma levels of epidurally administered lignocaine

The effects of two H2‐receptor antagonists, famotidine and cimetidine, on the plasma levels of epidurally administered lignocaine were studied. Group A (n = 20) received famotidine 20 mg orally the night before surgery and 20 mg intramuscularly 60 minutes before induction of anaesthesia. Group B (n = 15) received cimetidine 200 mg orally the night before the surgery and 400 mg orally 60 minutes before the anaesthetic induction. Group C (n = 20) received neither famotidine nor cimetidine and served as controls. Twelve millilitres of 2.0% lignocaine with adrenaline 1:200 000 was injected into the epidural space in all patients, after the establishment of general anaesthesia with nitrous oxide, oxygen, and enflurane (0.3–0.5%). The patients who received cimetidine showed significantly higher plasma concentrations of lignocaine compared with either group A or group C at all investigation times (p < 0.01). The mean peak plasma concentrations were 2.4 (SEM 0.1), 3.2 (SEM 0.2) and 2.3 (SEM 0.1) μg/ml in group A, B, and C, respectively. This study suggests that famotidine is preferable to cimetidine for control of gastric acidity before the use of lignocaine as the epidural anaesthetic.

[1]  A. Breckenridge,et al.  Lack of effect of ranitidine on warfarin action. , 1981, British Journal of Clinical Pharmacology.

[2]  L. Manchikanti,et al.  Cimetidine and Related Drugs in Anesthesia , 1982, Anesthesia and analgesia.

[3]  D. Triger.  Primary biliary cirrhosis: an epidemiological study. , 1980, British medical journal.

[4]  J. Brock‐Utne,et al.  Protection against pulmonary acid aspiration with ranitidine , 1982, Anaesthesia.

[5]  G. Keren,et al.  The cimetidine-lidocaine interaction. , 1983, Annals of internal medicine.

[6]  K. Amaha,et al.  [A double-blind evaluation of famotidine for pre-anesthetic intramuscular administration--its effects on volume and pH of gastric juice]. , 1987, Masui. The Japanese journal of anesthesiology.

[7]  T. Schwinghammer,et al.  Drug interactions with cimetidine. , 1981, American journal of hospital pharmacy.

[8]  C. Staiger,et al.  Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers [letter] , 1984 .

[9]  A. Somogyi,et al.  Drug Interactions with Cimetidine , 1982, Clinical pharmacokinetics.

[10]  F. M. Melewicz,et al.  Ranitidine and theophylline. , 1984, Annals of internal medicine.

[11]  T. Takagi,et al.  Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. , 1982, Archives internationales de pharmacodynamie et de therapie.

[12]  W. Kirch,et al.  Interactions and Non-interactions with Ranitidine , 1984, Clinical pharmacokinetics.

[13]  T. Takagi,et al.  Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats. , 1982, Arzneimittel-Forschung.

[14]  S. Dohi,et al.  Plasma Concentrations of Lidocaine Associated with Cervical, Thoracic, and Lumbar Epidural Anesthesia , 1983, Anesthesia and analgesia.

[15]  B. Kimelblatt,et al.  Cimetidine as an Inhibitor of Drug Metabolism: Therapeutic Implications and Review of the Literature , 1982, Drug intelligence & clinical pharmacy.

[16]  Y. M. Wang,et al.  Decreased oral warfarin clearance after ranitidine and cimetidine , 1984, Clinical pharmacology and therapeutics.

[17]  M. Miwa,et al.  Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects. , 1984, International journal of clinical pharmacology, therapy, and toxicology.